Zobrazeno 1 - 10
of 197
pro vyhledávání: '"E. M. Lemmel"'
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 113:172-176
In a multicenter, placebo-controlled and randomized double-blind trial 119 patients with rheumatoid arthritis were treated with thymopentin, an immunoregulating drug. The data of 107 patients were complete enough to be evaluated: 51 were given intrav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d8eaf98631412ab151e6d52bff778a3
https://doi.org/10.1055/s-2008-1067614
https://doi.org/10.1055/s-2008-1067614
Autor:
H. Hofmann, F. Husmann, H. Kather, G. Klein, G. Kölle, H.-F. Kumor, G. Lanzer, E.-M. Lemmel, R. Marx, H. Mathies, W. Miehle, H. P. Missmahl, W. Mohr, P. Otte, F. Rainer, M. Schattenkirchner, F. Schilling, Anneliese Schneider, P. Schneider, W. Schramm, W. Siegmeth, B. Simon, Elisabeth Stoeber, S. Stotz, F. J. Wagenhäuser, D. Wessinghage, G. L. Bach, G. Bartl, H. Behrend, Trude Behrend, U. Botzenhardt, D. Brackertz, Ute Donhauser-Gruber, J.-M. Engel, Rosemarie Filchner, A. Gruber, E. Gundel, H. Held
Autor:
S. Abdelhamid, H.-J. Beyer, A. Distler, E. Erdmann, K. Ewe, R. Ferlinz, J. Fischer, W. Fischer, E. Fuchs, H.-U. Gerbershagen, E. Hecking, F. Hertle, D. Höffler, J. Jahnecke, H. Just, L. Kanz, H. Köhler, G.J. Kremer, F. Krück, E.-M. Lemmel, K. Mainzer, K. Mann, K.-H. Meyer zum Büschenfelde, W. Ohler, M. Philipp, T. Philipp, P. Pfannenstiel, J. Preiß, W. Quarz, H.-P. Schuster, J. Schrezenmeir, P.M. Shah, H. Steppling, T.R. Weihrauch, H.J. Weis, H.P. Wolff, J. Wollenweber, H. Wollschläger
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b23bf103055fe5cd5a8511dbe417abd
https://doi.org/10.1016/b978-3-437-41652-1.01004-9
https://doi.org/10.1016/b978-3-437-41652-1.01004-9
Publikováno v:
Zeitschrift f�r Rheumatologie. 60:74-83
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60c56f832ab8c9c85b81ed245be0a357
https://doi.org/10.1007/s003930170077
https://doi.org/10.1007/s003930170077
Autor:
J. Braun, E. M. Lemmel, Dieter Felsenberg, Frank Buttgereit, Joachim Sieper, H. Franck, S.H. Scharla, Rolf Rau, R. Dreher, Gert Hein
Publikováno v:
Zeitschrift f�r Rheumatologie. 60:96-99
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::35f6ab0a3cad068f27d4ff29844e9453
https://doi.org/10.1007/s003930170081
https://doi.org/10.1007/s003930170081
Autor:
C. Oed, R Dahl, I Loew-Friedrich, Kim Hørslev-Petersen, A Rodriguez De La Serna, Dan Nordström, Michael G. Molloy, O Bjorneboe, Ferdinand C. Breedveld, J P Kaltwasser, Ronald Rosenburg, E M Lemmel, P T Dawes, F Van Den Bosch, B Gömör, Paul Emery, Mohammed Tikly
Publikováno v:
Scopus-Elsevier
Objective To compare the clinical efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis (RA). Methods In this multicentre, double-blind trial, 999 subjects with active RA were randomized to leflunomide (n = 501
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d57328d333f25b0cd46e6c2b0dce382
https://doi.org/10.1093/rheumatology/39.6.655
https://doi.org/10.1093/rheumatology/39.6.655
Publikováno v:
Der Internist. 39:368-372
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d6577e634482525e09d3795fced4648
https://doi.org/10.1007/s001080050184
https://doi.org/10.1007/s001080050184
Autor:
Ekkehard D. Albert, O. Niwa, Cornelia Epplen, Jörg T. Epplen, J. E. Saal, H. Menninger, Maria Gomolka, E. M. Lemmel
Publikováno v:
Journal of Molecular Medicine. 73:19-29
To identify genes that contribute to the manifestation of rheumatoid arthritis we performed association studies via microsatellite analyses of immunorelevant loci (HLA-DRB, 5 T cell receptor loci, TNFa IL1, IL2, IL5R and CD40L). A total of 183 patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8015e0fa2a59c824e11a0b368d567039
https://doi.org/10.1007/bf00203615
https://doi.org/10.1007/bf00203615
Autor:
E.-M. Lemmel
Publikováno v:
Rheumatology. 32:375-382
The efficacy and tolerability of pyritinol (PY) and auranofin (AU) were compared in a multicentre double-blind study. Patients with RA received 600 mg/day PY or 6 mg/day AU for 1 year. Response was rated by a defined improvement in at least four of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::333624294bbc07b326e2dec86dcf9067
https://doi.org/10.1093/rheumatology/32.5.375
https://doi.org/10.1093/rheumatology/32.5.375
Autor:
D. Richter, S. Schmid, P. H. Hofschneider, H. E. Stierle, Klaus Krüger, S. Herzig, W. Reemtsen, W. Gaus, U. Winter, H. D. Waller, W. H. Boesken, B. Brölz, J. R. Kalden, H. Warnatz, K. Wilms, A. K. von Kalle, C. Weyand, I. O. Auer, S. Meske, C. Gärtner, D. Brackertz, U. Botzenhardt, C. Stetter, Volker Diehl, M. Schattenkirchner, J. G. Saal, F. Strobel, H. J. Obert, K. Machalke, Hans-Hartmut Peter, T. Stolzenburg, R. Sprekeler, J. Goronzy, E. M. Lemmel, G. Lemm, C. Papst
Publikováno v:
Rheumatology International. 12:175-185
The controlled clinical trial reported here is part of a multicenter clinical and basic research project, sponsored by the German Federal Minister of Science and Technology, directed by a standing commission of the president of the Max-Planck-Gesells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a033a2e6e43cfb2b236fd3da71a338e
https://doi.org/10.1007/bf00302149
https://doi.org/10.1007/bf00302149